Home

Nantahala Capital Management reported a 9.99% stake in Quince Therapeutics QNCX · 4,765,862 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
9.99%
Last report
First report
Shares held
4,765,862 sh
Class
Common Stock, par value $0.001 per share
Event date
25/06/30
Filed
25/08/14

First 5%+ report · 9.99% stake

Quince Therapeutics trades, last 26 weeks

What else happened in Quince Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

Nantahala Capital Management's other 5% stake reports